See the pitch deck Theranica used for a $25 million Series C

Theranica
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

22
every slide · same image gating as the playbook
01
Slide 1
The slide serves as a cover/introductory slide for a pitch deck.front_matter
Open slide detailBeat · Setup
02
establish_context
Open slide detailBeat · SetupLoop · Golden Circle
03
The slide uses a split-background layout to distinguish between the Israel-based team and the USA-based team.other
Open slide detailBeat · SetupLoop · Golden Circle
04
size_opportunity
Open slide detailBeat · SetupLoop · Cost Of Inaction
05
Uses a 'Before-After' framing to contrast the negative side effects of pills with the benefits of the new technology.present_solution
Open slide detailBeat · SetupLoop · Cost Of Inaction
06
The slide emphasizes the ease of use and discretion of the wearable device.present_solution
Open slide detailBeat · EvidenceLoop · Cost Of Inaction
07
The slide uses a combination of icons and bullet points to highlight product value proposition.present_solution
Open slide detailBeat · EvidenceLoop · Cost Of Inaction
08
The slide uses a process flow to explain the biological mechanism of the product (Nervio).present_solution
Open slide detailBeat · EvidenceLoop · Cost Of Inaction
09
The slide uses a hub-and-spoke model to show how data is collected from patients, processed in the cloud, and utilized by HCPs.present_solution
Open slide detailBeat · EvidenceLoop · Cost Of Inaction
10
This slide serves as a transition or header for a section on clinical data, featuring the product hardware and software UI.present_solution
Open slide detailBeat · EvidenceLoop · Cost Of Inaction
11
The slide demonstrates clinical validation through a list of 12 distinct studies.show_traction
Open slide detailBeat · EvidenceLoop · Cost Of Inaction
12
The chart explicitly notes it is not a head-to-head comparison.compare_peers
Open slide detailBeat · EvidenceLoop · Cost Of Inaction
13
The slide uses a bar chart to visually demonstrate that Nerivio has a significantly lower adverse event (AE) rate compared to pharmaceutical alternatives.compare_peers
Open slide detailBeat · EvidenceLoop · Cost Of Inaction
14
The chart compares REN (green) vs Prescribed Meds (yellow) across two metrics: Pain Relief and Pain Freedom.compare_peers
Open slide detailBeat · EvidenceLoop · Cost Of Inaction
15
The table highlights specific clinical trial metrics (Pain free 2h, Pain relief 2h, Sustained Pain Relief) and uses red text to highlight potential disadvantagecompare_peers
Open slide detailBeat · DevelopmentLoop · Cost Of Inaction
16
The slide uses a timeline-based table to show progress across different clinical stages (Proof of Concept, Pivotal, FDA Clearance).plan_implementation
Open slide detailBeat · DevelopmentLoop · Cost Of Inaction
17
transition
Open slide detailBeat · DevelopmentLoop · Cost Of Inaction
18
The slide uses a combination of big numbers and logo-based social proof to demonstrate market validation.show_traction
Open slide detailBeat · DevelopmentLoop · Cost Of Inaction
19
The slide uses a flow-chart style diagram to map communication channels to specific target audiences.plan_implementation
Open slide detailBeat · DevelopmentLoop · Cost Of Inaction
20
Uses a specific persona (Jessica Smith) to anchor the financial argument.illustrate_case
Open slide detailBeat · ActionLoop · Cost Of Inaction
21
The slide illustrates a circular process flow involving patient, digital platform, insurance, pharmacy, and delivery.present_solution
Open slide detailBeat · ActionLoop · Golden Circle
22
state_next_steps
Open slide detailBeat · ActionLoop · Golden Circle